WallStreetZenWallStreetZen

NYSE: RDY
Dr Reddys Laboratories Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Dr Reddys Laboratories earnings were $668.3M for the trailing 12 months ending Mar 31, 2024, with 21.7% growth year over year. For the last reported fiscal year 2024 ending Mar 31, 2024, RDY reported annual earnings of $668.1M, with 21.9% growth. The next RDY earnings date is Jan 28, 2025.

RDY past earnings growth

How has RDY's earnings growth performed historically?

Company
21.67%
Industry
25.74%
Market
49.45%
RDY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
RDY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
RDY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

RDY earnings history

Current Revenue
$3.3B
Current Earnings
$668.1M
Current Profit Margin
19.9%
RDY's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

RDY Return on Equity

Current Company
21.8%
Current Industry
13.6%
Current Market
25.1%
RDY's Return on Equity (21.8%)... subscribe to Premium to read more.
High Return on Equity Performance

RDY Return on Assets

Current Company
15.7%
Current Industry
3.5%
RDY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when RDY announces earnings.

RDY Return on Capital Employed

Current Company
25.24%
Current Industry
5.8%
RDY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RDY vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
RDY$1.06B$668.31M+19.68%$0.80
CTLT$399.00M-$413.00MN/A-$2.29
NBIX$549.50M$385.90M+75.78%$3.86
VTRS$2.41B-$883.30MN/A-$0.72
ITCI-$84.60M-$86.37MN/A-$0.87
View Top Pharmaceutical Stocks

RDY earnings dates

Next earnings date
Jan 28, 2025

Dr Reddys Laboratories Earnings Reports & History FAQ

What was RDY's earnings growth in the past year?

As of Dr Reddys Laboratories's earnings date in Invalid Date, Dr Reddys Laboratories's earnings has grown 21.67% year over year. This is 4.07 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 25.74%. RDY earnings in the past year totalled $668.31 million.

If you're new to stock investing, here's how to buy Dr Reddys Laboratories stock.

Is Dr Reddys Laboratories profitable or losing money?

As of the last Dr Reddys Laboratories earnings report, Dr Reddys Laboratories is currently profitable. Dr Reddys Laboratories's net profit (also called net income) for the twelve months ending Mar 31, 2024 was $668.07 million, a 21.85% increase year over year.

When does Dr Reddys Laboratories report earnings?

The next RDY earnings call is Invalid Date. Add RDY to your watchlist to be reminded of Dr Reddys Laboratories's next earnings date.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.